Production of lymphoid tissue effector cells reactive against ca

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3578

Patent

active

047724692

ABSTRACT:
The addition of small amounts of MER to an in vitro culture of animal or human lymphocytes together with cancer cells will greatly potentiate the process by which the lymphocytes become actively cytotoxic to the specific type of cancer cells when injected in vivo. In some cases MER causes sensitization of the lymphocytes even when there is none without the MER. MER cultured in vitro with lymphocytes without specific cancer cells in the culture will cause non-specific cytotoxic sensitization of the lymphocytes. The sensitized cytotoxic reactive cells may be stored cryogenically for use in human cancer therapy.

REFERENCES:
Kedar et al., J. Natl. Cancer Inst. 60: 1097-1106 (1978).
Kedar, J. Immunol. Methods 26: 157-171 (1979).
Kedar et al., J. Immunol. Methods 28: 303-319 (1979).
Kedar et al., J. Immunol. Methods 16: 39-58.
Weiss, Proceedings of the 5th Berkeley Symposium, Berkeley, 1967, pp. 657-706.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Production of lymphoid tissue effector cells reactive against ca does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Production of lymphoid tissue effector cells reactive against ca, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of lymphoid tissue effector cells reactive against ca will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1747650

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.